Deal Making

Featured on Deal Making

CTMC partners with Ori Bio to advance cell therapy processes
Deal-Making
CTMC partners with Ori Bio to advance cell therapy processesCTMC partners with Ori Bio to advance cell therapy processes

The CTMC will be granted precommercial access to Ori Biotech’s paperless technology platform through the partnership.

byMillie Nelson
Sep 13, 2022
|
2 Min Read
NexImmune to use Selexis tech to develop immunotherapies
Deal-Making
NexImmune to use Selexis tech to develop immunotherapiesNexImmune to use Selexis tech to develop immunotherapies
byMillie Nelson
Sep 12, 2022
2 Min Read
Investing in small molecule derisks our portfolio, says Bone Therapeutics
Deal-Making
Investing in small molecule derisks our portfolio, says Bone TherapeuticsInvesting in small molecule derisks our portfolio, says Bone Therapeutics
byMillie Nelson
Sep 12, 2022
2 Min Read
Neukio Bio raises $50m for allogenic CAR-T therapies
Deal-Making
Neukio Bio raises $50m for allogenic CAR-T therapiesNeukio Bio raises $50m for allogenic CAR-T therapies
byRichard Daverman
Sep 9, 2022
3 Min Read
Lonza boosts mRNA services through Touchlight collaboration
Deal-Making
Lonza boosts mRNA services through Touchlight collaborationLonza boosts mRNA services through Touchlight collaboration
byDan Stanton
Sep 8, 2022
2 Min Read
LuinaBio: Ampersand adds another CDMO to portfolio
Deal-Making
LuinaBio: Ampersand adds another CDMO to portfolioLuinaBio: Ampersand adds another CDMO to portfolio
byDan Stanton
Sep 1, 2022
2 Min Read

More from Deal Making

ElevateBio inks deal with Pittsburgh University to accelerate CGTs
Deal-Making
ElevateBio inks deal with Pittsburgh University to accelerate CGTs
ElevateBio inks deal with Pittsburgh University to accelerate CGTs
Sep 1, 2022
|
2 Min Read
byMillie Nelson
Cytiva and ForecyteBio partner to advance CGTs
Deal-Making
Cytiva and ForecyteBio partner to advance CGTs
Cytiva and ForecyteBio partner to advance CGTs
Aug 31, 2022
|
1 Min Read
byMillie Nelson
ChargePoint ups SU tech with PuroVaso buy
Deal-Making
ChargePoint ups SU tech with PuroVaso buy
ChargePoint ups SU tech with PuroVaso buy
Aug 30, 2022
|
1 Min Read
byMillie Nelson
Novartis waves goodbye to biosimilars with Sandoz split
Deal-Making
Novartis waves goodbye to biosimilars with Sandoz split
Novartis waves goodbye to biosimilars with Sandoz split
Aug 26, 2022
|
2 Min Read
byDan Stanton
Cytiva and Caring Cross to develop CAR-T for HIV
Deal-Making
Cytiva and Caring Cross to develop CAR-T for HIV
Cytiva and Caring Cross to develop CAR-T for HIV
Aug 25, 2022
|
2 Min Read
byMillie Nelson
Bavarian Nordic inks fill/finish deal with GRAM for monkeypox vaccine
Deal-Making
Bavarian Nordic inks fill/finish deal with GRAM for monkeypox vaccine
Bavarian Nordic inks fill/finish deal with GRAM for monkeypox vaccine
Aug 22, 2022
|
2 Min Read
byMillie Nelson
Vendor identity: Catalent could enter the CDMO elite with Repligen buy
Deal-Making
Vendor identity: Catalent could enter the CDMO elite with Repligen buy
Vendor identity: Catalent could enter the CDMO elite with Repligen buy
Aug 22, 2022
|
4 Min Read
byDan Stanton
Gilead buys back China rights to ADC Trodelvy for $455m
Global Markets
Gilead buys back China rights to ADC Trodelvy for $455m
Gilead buys back China rights to ADC Trodelvy for $455m
Aug 19, 2022
|
2 Min Read
byRichard Daverman
Merck enters $221m 'circular’ RNA partnership with Orna
Deal-Making
Merck enters $221m 'circular’ RNA partnership with Orna
Merck enters $221m 'circular’ RNA partnership with Orna
Aug 18, 2022
|
2 Min Read
byMillie Nelson
Mayo Clinic and Resilience enter biomanufacturing pact
Deal-Making
Mayo Clinic and Resilience enter biomanufacturing pact
Mayo Clinic and Resilience enter biomanufacturing pact
Aug 18, 2022
|
2 Min Read
byDan Stanton
Tonix looks to live virus vaccines to prevent the spread of monkeypox
Therapeutic Class
Tonix looks to live virus vaccines to prevent the spread of monkeypox
Tonix looks to live virus vaccines to prevent the spread of monkeypox
Aug 16, 2022
|
3 Min Read
byMillie Nelson
Sanofi inks cancer antibody deal and invests $305m in Innovent
Global Markets
Sanofi inks cancer antibody deal and invests $305m in Innovent
Sanofi inks cancer antibody deal and invests $305m in Innovent
Aug 11, 2022
|
3 Min Read
byRichard Daverman
Sartorius lays out $500m to buy recombinant albumin firm Albumedix
Upstream & Downstream Processing
Sartorius lays out $500m to buy recombinant albumin firm Albumedix
Sartorius lays out $500m to buy recombinant albumin firm Albumedix
Aug 9, 2022
|
2 Min Read
byDan Stanton
Roche inks $110m allogeneic CAR-T deal with Poseida
Therapeutic Class
Roche inks $110m allogeneic CAR-T deal with Poseida
Roche inks $110m allogeneic CAR-T deal with Poseida
Aug 5, 2022
|
2 Min Read
byDan Stanton
Further CDMO consolidation in CGT space as RoslinCT and Lykan agree to merge
Deal-Making
Further CDMO consolidation in CGT space as RoslinCT and Lykan agree to merge
Further CDMO consolidation in CGT space as RoslinCT and Lykan agree to merge
Aug 5, 2022
|
3 Min Read
byDan Stanton
CGT Catapult joins personalized cell therapy consortium
Deal-Making
CGT Catapult joins personalized cell therapy consortium
CGT Catapult joins personalized cell therapy consortium
Aug 4, 2022
|
2 Min Read
byMillie Nelson
Merck forks out $35m for Kelun-Biotech ADC deal
Deal-Making
Merck forks out $35m for Kelun-Biotech ADC deal
Merck forks out $35m for Kelun-Biotech ADC deal
Aug 4, 2022
|
1 Min Read
byMillie Nelson
Pandemic preparedness: GSK enters agreement with 12 EU countries
Deal-Making
Pandemic preparedness: GSK enters agreement with 12 EU countries
Pandemic preparedness: GSK enters agreement with 12 EU countries
Aug 2, 2022
|
2 Min Read
byMillie Nelson
Sartorius M&A ready with €10bn war chest
Upstream & Downstream Processing
Sartorius M&A ready with €10bn war chest
Sartorius M&A ready with €10bn war chest
Aug 1, 2022
|
2 Min Read
byDan Stanton
Ginkgo forks out $300m to acquire Zymergen
Deal-Making
Ginkgo forks out $300m to acquire Zymergen
Ginkgo forks out $300m to acquire Zymergen
Jul 27, 2022
|
2 Min Read
byMillie Nelson
Lonza H1: Biologics biz boosted by $130m Allakos cancellation fee
Facilities & Capacity
Lonza H1: Biologics biz boosted by $130m Allakos cancellation fee
Lonza H1: Biologics biz boosted by $130m Allakos cancellation fee
Jul 27, 2022
|
2 Min Read
byDan Stanton
TFBS to grow viral vector ops with help from Univercells
Deal-Making
TFBS to grow viral vector ops with help from Univercells
TFBS to grow viral vector ops with help from Univercells
Jul 27, 2022
|
2 Min Read
byMillie Nelson
Lenti of deals: Oxford Biomedica inks two agreements
Deal-Making
Lenti of deals: Oxford Biomedica inks two agreements
Lenti of deals: Oxford Biomedica inks two agreements
Jul 26, 2022
|
3 Min Read
byMillie Nelson
Roche and Avista ink deal to develop AAV gene therapy vectors for eyes
Deal-Making
Roche and Avista ink deal to develop AAV gene therapy vectors for eyes
Roche and Avista ink deal to develop AAV gene therapy vectors for eyes
Jul 22, 2022
|
1 Min Read
byMillie Nelson
Study results led to the acquisition of GeneTx, says Ultragenyx
Deal-Making
Study results led to the acquisition of GeneTx, says Ultragenyx
Study results led to the acquisition of GeneTx, says Ultragenyx
Jul 20, 2022
|
2 Min Read
byMillie Nelson
BeiGene teams with InnoRNA to develop mRNA therapeutics
Global Markets
BeiGene teams with InnoRNA to develop mRNA therapeutics
BeiGene teams with InnoRNA to develop mRNA therapeutics
Jul 15, 2022
|
2 Min Read
byRichard Daverman
Solvias boosts CGT testing with Cergentis acquisition
Deal-Making
Solvias boosts CGT testing with Cergentis acquisition
Solvias boosts CGT testing with Cergentis acquisition
Jul 14, 2022
|
2 Min Read
byBPI Staff
Emergent to make Ebola mAb for Ridgeback
Deal-Making
Emergent to make Ebola mAb for Ridgeback
Emergent to make Ebola mAb for Ridgeback
Jul 14, 2022
|
2 Min Read
byMillie Nelson
LG Chem licensing electroporation tech from MaxCyte
Deal-Making
LG Chem licensing electroporation tech from MaxCyte
LG Chem licensing electroporation tech from MaxCyte
Jul 13, 2022
|
1 Min Read
byMillie Nelson
Vertex to tighten grip on diabetes islet cell space with $320m ViaCyte buy
Deal-Making
Vertex to tighten grip on diabetes islet cell space with $320m ViaCyte buy
Vertex to tighten grip on diabetes islet cell space with $320m ViaCyte buy
Jul 12, 2022
|
2 Min Read
byDan Stanton

Webinars

Ask the Expert webcasts
ATE Webcasts
Register Now: From Concept to Cleanroom - Case Studies in Single-Use Fluid Management CollaborationRegister Now: From Concept to Cleanroom - Case Studies in Single-Use Fluid Management Collaboration
Ask the Expert webcasts
ATE Webcasts
Register Now: Process Intensification Through Perfused N-1 BioreactorRegister Now: Process Intensification Through Perfused N-1 Bioreactor
Ask the Expert webcasts
ATE Webcasts
Register Now: Building Reliability Into Scale-Up: Targeted Optimization for AAV ProductionRegister Now: Building Reliability Into Scale-Up: Targeted Optimization for AAV Production
Insider News
See all
Sep 23 - Sep 26, 2024
Learn from the brightest minds in bioprocessing! The BPI US 2024 scientific agenda includes 200+ of the industry's top scientists to present the latest updates on how to improve efficiencies across all phases of biopharmaceutical development and production.
Learn More

Innovative Technology

Mettler Toledo WP
Sponsored Content
Elevate Single-Use Bioreactor Performance with Digital Single-Use pH SensorsElevate Single-Use Bioreactor Performance with Digital Single-Use pH Sensors
byBPI Contributor
Sep 6, 2024
1 Min Read
Thermo Fisher Plan for Success WP
Sponsored Content
Increase Efficiency and Reduce Costs in Bioprocessing: A Strategic GuideIncrease Efficiency and Reduce Costs in Bioprocessing: A Strategic Guide
byBPI Contributor
Aug 14, 2024
1 Min Read
Valgenesis transforming pharmaceutical development
Sponsored Content
Transforming Pharmaceutical Development: Combining Digital Platforms and QbD PrinciplesTransforming Pharmaceutical Development: Combining Digital Platforms and QbD Principles
byBPI Contributor
Aug 7, 2024
1 Min Read